MedTrace Logo

Clinical Evaluation of a Myopia Control Lens in Slowing Myopia Progression (DAL)

NCT05840185 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-11-29

No results posted yet for this study

Summary

This is a mono-centre, prospective, one-arm, unmask clinical trial to evaluate the effectiveness of test lens in slowing myopia progression with respect to axial length elongation compared to a single vision spectacle lens from the historical control group of another clinical trial NCT05331378. A total of 40 children will be recruited

Conditions

  • Myopia

Interventions

DEVICE

Test myopia control lenses (DAL)

A pair of myopia control spectacle lenses (test lenses) will be given to subjects to wear for 12 months

Sponsors & Collaborators

  • Essilor International

    lead INDUSTRY

Principal Investigators

  • Wee Sing Ong · Essilor R&D Centre Singapore

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
8 Years
Max Age
13 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-10
Primary Completion
2024-08-31
Completion
2024-08-31

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05840185 on ClinicalTrials.gov